An Unexpected Opiate Result

An adult outpatient urine drug screen is ordered after an unexpected change in mental status. The local clinical immunoassay reports opiates positive at a 300 ng/mL cutoff. For fentanyl, no assay signal met the 2 ng/mL cutoff for the tested fentanyl target in that specimen; this does not exclude exposure outside the target, cutoff, specimen timing, or detection window. The medication list includes a standing morphine order given the evening before collection. What this result shows about exposure, and what it cannot establish, depends on the method and the history.

An opiate-class immunoassay measures a class reaction near its stated cutoff, not a named drug identity. A positive result may be compatible with morphine or codeine exposure, but its interpretation depends on the assay target and local report language. A negative drug-specific fentanyl or oxycodone screen does not confirm or exclude the cause of the opiate-class reaction. Detection is not evidence of dose, timing, impairment, or behavior.

The result needs method information, specimen context, medication history, and a decision about definitive testing. Because this result may affect clinical management and the history does not fully explain the picture, the laboratory should follow its local reflex or order workflow. Release the screen as presumptive and state the analyte limits before attaching a clinical meaning.